Digene Corp. will develop a cervical cancer test designed for use in the developing world, where the largely preventable disease kills about 200,000 women a year, the Gaithersburg biotechnology ...
Digene Corp. of Gaithersburg will pay a New York biotechnology company at least $30.5 million to settle a patent-infringement lawsuit involving technology used in its leading product, the only ...
Digene Corp., a Gaithersburg-based maker of diagnostic tests, announced yesterday the termination of its merger with Cytyc Corp. The decision was widely expected after the Federal Trade Commission ...
Facing increased competition for its main product – the HPV Test – and questions about its plans for growth, Gaithersburg’s Digene Corp. agreed yesterday to be acquired by a foreign company in a $1.6 ...
Digene Corp., a maker of molecular diagnostic tests and rival of Third Wave Technologies Inc. in Madison, has agreed to be acquired by Qiagen NV of Venlo, Netherlands, which also specializes in ...
Shares of Digene, a maker of DNA and RNA tests, sizzled on Monday after it announced that Netherlands-based Qiagen would purchase the company in a $1.6 billion deal. Digene is best known for a test to ...
Qiagen, a Dutch manufacturer of genetic testing equipment, announced Sunday it will purchase Digene Corp. for $1.6 billion in cash and stock. Digene produces DNA and RNA screening tests for cervical ...
The diagnostic firm Digene Corp. is raising $56 million in gross proceeds by way of a public offering announced after Wednesday's market close. Management at the Gaithersburg, Md.-based company ...
QIAGEN N.V. and Digene Corp. have announced a definitive agreement to combine the two companies to create market- and technology-leadership in molecular diagnostics. The Boards of Directors of both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results